An ultra‐long‐acting recombinant insulin for the treatment of diabetes mellitus in cats
An ultra‐long‐acting recombinant insulin for the treatment of diabetes mellitus in cats
About this item
Full title
Author / Creator
Publisher
Hoboken, USA: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Hoboken, USA: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Background
Treatment of diabetes mellitus (DM) in cats typically requires insulin injections q12h‐q24h, posing a major compliance barrier for caregivers. Novel treatments enabling decreased injection frequency while maintaining safety are highly desirable. Insulin fused with feline immunoglobulin fragment crystallizable (Fc) has an ultra‐long pl...
Alternative Titles
Full title
An ultra‐long‐acting recombinant insulin for the treatment of diabetes mellitus in cats
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5997d34775024833b8e2b78436ce3173
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5997d34775024833b8e2b78436ce3173
Other Identifiers
ISSN
0891-6640
E-ISSN
1939-1676
DOI
10.1111/jvim.16150
